Montelukast Prescribing at HOLMCROFT
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
765
Total Quantity
30.1K
NHS Cost
£1.5K
vs National Avg
+11.7%
HOLMCROFT prescribed 765 items of Montelukast over the last 12 months at a cost of £1,460 to the NHS. This is 11.7% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
67
Jun 2026
67
Jun 2026
69
Jun 2026
71
Jun 2026
65
Jun 2026
71
Jun 2026
56
Jun 2026
68
Jun 2026
64
Jun 2026
52
Jun 2026
56
Jun 2026
59
Prescribing Details
| Total Items | 765 |
|---|---|
| Total Quantity | 30,100 |
| Total NHS Cost | £1,460 |
| Presentations | 4 different forms |
| vs National Average | +11.7% |
Montelukast Prescribing Comparison
| This practice | 765 items |
|---|---|
| National average per practice | 685 items |
| Difference | +11.7% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.